Results 11 to 20 of about 20,292 (247)

Lipoprotein(a), family history, and incidence of premature ASCVD events in a pooled US cohort

American Journal of Preventive Cardiology
Background: Lipoprotein(a) [Lp(a)] is an independent, genetic, and causal risk factor for atherosclerotic cardiovascular disease (ASCVD). There are limited data on its impact on premature ASCVD, including in diverse populations and with family history ...
Yihang Fan, Wenjun Fan, Xingdi Hu, Michael Y. Tsai, Ron C. Hoogeveen, Matthew J. Budoff, Nathan D. Wong   +6 more
doaj   +2 more sources

VLDL cholesterol and ASCVD risk: A population-based study

Journal of Clinical Lipidology
Observational and genetic evidence show associations of high remnant cholesterol levels with atherosclerotic cardiovascular disease (ASCVD). New drugs have been developed that substantially lower remnant cholesterol; however, the corresponding absolute risk reduction of ASCVD remains unclear.
Mie Balling, Otto Grøn Roepstorff, Thomas Alexander Gerds, Anette Varbo, Anne Langsted, Martin Bødtker Mortensen, George Davey Smith, Børge Grønne Nordestgaard, Shoaib Afzal   +8 more
openaire   +5 more sources

QRISK 3® and ASCVD Risk Calculator in Patients with Diabetes and Their Correlation with Coronary Artery Calcium Scores

Indian Journal of Endocrinology and Metabolism
Introduction: Diabetes mellitus is an independent risk factor for asymptomatic cardiovascular disease (CVD). The QRISK 3® score and atherosclerotic cardiovascular disease (ASCVD) risk scores determine the risk of developing CVD over 10 years.
Subramanian Kannan, Murali M. B. Venkataraman, Salila S. Chandorkar   +2 more
doaj   +2 more sources

Lipid Control Post Coronary Artery Bypass Graft: One Year Follow-Up of a Middle-Eastern Cohort

Global Heart, 2020
Background: Data on patient characteristics and provider practices in the management of lipids per the new guidelines in specific secondary prevention patients in the Middle East is limited.
Bassam Atallah, Ramzi Khaddage, Ziad G. Sadik, Saad I. Mallah, Terrence J. Lee-St. John, Shamsah Alfardan, Mahmoud I. Traina, Wael Almahmeed   +7 more
doaj   +1 more source

Health Literacy is Essential to ASCVD Prevention in Youth

Current Atherosclerosis Reports, 2023
Abstract Purpose of Review Health literacy is fundamental to primary and primordial prevention of atherosclerotic vascular disease (ASCVD) in children and adolescents. Here we summarize essential components of interventions which address health literacy challenges to reduce ASCVD risk in youth ...
Harnoor K. Mann, Jared W. Magnani, Amber E. Johnson   +2 more
openaire   +2 more sources

Physicians’ attitudes toward ASCVD risk assessment.

, 2022
Physicians’ attitudes toward ASCVD risk assessment.
Abdulsalam Halboup (11575362), Siti Maisharah Sheikh Ghadzi (9761659), Fahmi Y. Al-Ashwal (9761647), Syed Azhar Syed Sulaiman (9761656), Mohammed Abdullah Kubas (11575359)   +4 more
core   +1 more source

Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) StudyPlain-Language Summary

Kidney Medicine, 2021
Rationale & Objective: The 2018 American Heart Association/American College of Cardiology (AHA/ACC) cholesterol guideline uses risk stratification to guide the decision to initiate nonstatin lipid-lowering medication among adults with atherosclerotic
Bharat Poudel, Robert S. Rosenson, Vera Bittner, Orlando M. Gutiérrez, Amanda H. Anderson, Mark Woodward, Rajat Deo, April P. Carson, Katherine E. Mues, Paul J. Dluzniewski, Bernard G. Jaar, Claudia M. Lora, Jonathan Taliercio, Paul Muntner, Lisandro D. Colantonio   +14 more
doaj   +1 more source

Semaglutide 2.4 mg Cardiometabolic Long-Term Effects in Patients With Obesity or Overweight in a Real-World Setting: A Retrospective Cohort Study in the United States (SMILE). [PDF]

Diabetes Obes Metab
ABSTRACT Aims To evaluate the real‐world associations between semaglutide 2.4 mg and cardiometabolic comorbidities, biomarkers and cardiovascular risk among adults with overweight or obesity. Methods This retrospective cohort study used US claims data and laboratory measurements from the Komodo Research Database (2016–2024). Adults with obesity or with
Ruseva A, Michalak W, Bassan M, Du EX, Fabricatore A, Hartaigh BÓ, Man T, Ramasubramanian R, Shen P, Song J, Zhao Z, Lopez-Jimenez F.   +11 more
europepmc   +2 more sources

Oxidative Stress Underpins Clinical, Social, and Genetic Risk Factors for Atherosclerotic Cardiovascular Disease

Clinical Medicine Insights: Cardiology, 2023
Background: Atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of death worldwide and is poorly predicted with current risk estimation tools.
Emily Mewborn, Ansley Stanfill
doaj   +1 more source

Periodontitis and atherosclerotic cardiovascular disease: A critical appraisal

Periodontology 2000, EarlyView., 2023
Abstract In spite of intensive research efforts driving spectacular advances in terms of prevention and treatments, cardiovascular diseases (CVDs) remain a leading health burden, accounting for 32% of all deaths (World Health Organization. “Cardiovascular Diseases (CVDs).” WHO, February 1, 2017, https://www.who.int/news‐room/fact‐sheets/detail ...
Maria Clotilde Carra, Hélène Rangé, Giuseppina Caligiuri, Philippe Bouchard   +3 more
wiley   +1 more source